You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgens

Showing 51 - 75 of 734
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Sherbrooke (Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade)

Active, not recruiting
  • Prostate Cancer
  • Radiotherapy 70 Gy
  • +2 more
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

In-vitro Diagnostic Test to Predict COVID-19 Mortality and

Recruiting
  • SARS-CoV 2
  • +5 more
  • CAG length <22
  • CAG length >=22
  • Madrid, Spain
    Hospital Universitario Ramon y Cajal
Feb 17, 2022

Anovulatory Disorders in Lean and Overweight Women

Recruiting
  • Menstrual Cycle Abnormal
  • +3 more
    • New York, New York
      Clinical and Translational Science Center
    Sep 23, 2022

    Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

    Not yet recruiting
    • Prostate Cancer
    • Darolutamide Oral Tablet [Nubeqa]
    • (no location specified)
    Jun 2, 2023

    Dietary Supplements Trial in Kaohsiung (DHEA, DHEA+CoQ10+Tocotrienol)

    Recruiting
    • Dietary Supplements
    • DHEA
    • DHEA+CoQ10+Tocotrienol
    • Kaohsiung, Taiwan
      Department of Obstetrics and Gynecology, Kaohsiung Veterans Gene
    Jul 21, 2022

    Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • Castration-Sensitive Prostate Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Feb 4, 2023

    Prostate Cancer Trial in Sherbrooke (Androgen blockade + radiation therapy)

    Active, not recruiting
    • Prostate Cancer
    • Androgen blockade + radiation therapy
    • Sherbrooke, Quebec, Canada
      Centre de Recherche Clinique du CHUS
    May 20, 2022

    Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +5 more
    Jul 14, 2022

    Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)

    Active, not recruiting
    • Congenital Adrenal Hyperplasia (CAH)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

    Active, not recruiting
    • Adenocarcinoma of the Prostate
    • Radiation Therapy
    • Androgen Deprivation Therapy (ADT)
    • Washington, District of Columbia
    • +2 more
    Oct 25, 2022

    Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

    Not yet recruiting
    • Prostate Cancer
    • +2 more
    • Apalutamide 60mg Tab
    • Androgen deprivation therapy(ADT)
    • Nanjing, Jiangsu, China
    • +2 more
    Mar 17, 2023

    Measurement of Serum microRNA in Acne Vulgaris Patient

    Not yet recruiting
    • Acne Vulgaris
    • measure serum MicroRNA in acne vulgaris
    • (no location specified)
    May 23, 2023

    Prostate Cancer Trial in Durham (drug, radiation, procedure)

    Not yet recruiting
    • Prostate Cancer
    • Durham, North Carolina
      Duke University Medical Center
    Aug 16, 2022

    Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Weill Cornell Medicine - New York Presbyterian Hospital
    Oct 3, 2022

    Hypogonadism, Hypogonadotropic, Obesity Trial in Houston (anastrozole (1 mg/day), Placebo)

    Recruiting
    • Hypogonadism, Hypogonadotropic
    • Obesity
    • anastrozole (1 mg/day)
    • Placebo
    • Houston, Texas
      Michael E. DeBakey VAMC
    Jan 19, 2022

    Idiopathic Intracranial Hypertension Trial in Montpellier (Blood punction, Central blood sampling, Intracranial pressure

    Not yet recruiting
    • Idiopathic Intracranial Hypertension
    • Blood punction
    • +2 more
    • Montpellier, France
      University Hospital of Montpellier - Gui de Chauliac
    Oct 2, 2023

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

    Not yet recruiting
    • Androgen Deprivation Therapy
    • +4 more
    • Gonadotropin-Releasing Hormone Agonist
    • +2 more
    • (no location specified)
    Jan 18, 2023

    Polycystic Ovary Syndrome, Insulin Resistance Trial in San Francisco (Vigorous Exercise, Moderate Exercise)

    Active, not recruiting
    • Polycystic Ovary Syndrome
    • Insulin Resistance
    • Vigorous Exercise
    • Moderate Exercise
    • San Francisco, California
      UCSF Center for Reproductive Health
    Dec 1, 2022

    Effect of ADT in Prostate Cancer Asia (READT Asia Study)

    Recruiting
    • Prostate Cancer
    • Androgen deprivation therapy - bilateral orchidectomy
    • +2 more
    • Shatin, Hong Kong
      Prince of Wales Hospital
    Dec 14, 2021

    Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 11, 2022

    Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

    Recruiting
    • Prostate Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 27, 2021

    Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Product
    • +2 more
    • Cincinnati, Ohio
      University of Cincinnati Medical Center
    Mar 27, 2023

    Dyspareunia Trial in San Diego (Prasterone)

    Completed
    • Dyspareunia
    • San Diego, California
      San Diego Sexual Medicine
    Jun 8, 2022